drug · antibody
gefurulimab
pre_registrationupdated 6mo agoby Alexion Pharmaceuticals Inc🔗 ChEMBL
community read0 votes
Antibody drug with a maximum clinical stage of Phase 3 (across all indications), with 2 investigational indications.
all catalysts(0)
nothing on the calendar yet
Trials studying gefurulimab
- phase3PK, PD, Safety, and Efficacy Study of Gefurulimab in Pediatric Patients With AChR+ Generalized Myasthenia Gravis
- phase1PK Study of Gefurulimab SC in Healthy Chinese Adult Participants
- phase1A Study of Subcutaneous Gefurulimab Using Prefilled Syringe Versus Autoinjector in Healthy Adult Participants
News(1)
- AstraZeneca, Alexion's mysathenia gravis treatment enters crowded marketAstraZeneca and Alexion won FDA approval Monday for their self-administered generalized myasthenia gravis (gMG) drug Klygefa. The drug, also known as gefurulimab, is a once-weekly treatment for pat…endpoints · 16h ago
Data sources
last refreshed 4h ago
Found something off?
comments(0)
5-min edit window · permanent after that